PSIVIDA CORP (PSDV)

Overview Price 2.11 Price Change Today +$0.06 (+2.93%) P&P rating Zacks Rank 2 - BUY Open Price $2.06 Previous Close $2.05 Daily Range $2.02 - $2.12 52-Week Range $1.02 - $5.23 Volume 19,573 PSIVIDA CORP is a global drug delivery company committed to the biomedical sector and the development of drug delivery products. Retisert is FDA approved for the treatment of uveitis. Vitrasert is FDA approved for the treatment of AIDS-related CMV Retinitis. Bausch & Lomb owns the trademarks Vitrasert and Retisert. pSivida has licensed the technologies underlying both of these products to Bausch & Lomb. The technology underlying Medidur for diabetic macular edema is licensed to Alimera Sciences and is in Phase III clinical trials. pSivida has a worldwide collaborative research and license agreement with Pfizer Inc. for other ophthalmic applications of the Medidur technology (excluding FA). Other Resources for PSDV Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. PSIVIDA CORP is a global drug delivery company committed to the biomedical sector and the development of drug delivery products. Retisert is FDA approved for the treatment of uveitis. Vitrasert is FDA approved for the treatment of AIDS-related CMV Retinitis. Bausch & Lomb owns the trademarks Vitrasert and Retisert. pSivida has licensed the technologies underlying both of these products to Bausch & Lomb. The technology underlying Medidur for diabetic macular edema is licensed to Alimera Sciences and is in Phase III clinical trials. pSivida has a worldwide collaborative research and license agreement with Pfizer Inc. for other ophthalmic applications of the Medidur technology (excluding FA).   Brokerage Analyst Recommendations 2 Brokerage Firms Covering PSDV   Strong Buy 1 Buy 0 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 2   PSDV Ratings: BUY  SELL  HOLD PSDV Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 5 Buy 0 Sell   Top Buy Analysis BUY: PSDV Company: PSIVIDA LIMITED - AMERICAN DEPOSITOR Points: -56.52 Start Price: $5.09 Start Date: 07/23/2011 6:53 PM FGS P&P Score: 0.00 Recs: For capital appreciation Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

No related Blog Posts.

Commentary

BUY: PSIVIDA LIMITED - AMERICAN DEPOSITOR (PSDV) Start Price: $5.09 Points: -56.52 Created: 07/23/2011 For capital appreciation Comments: 0 | Comment FGS Recs:

BUY: PSIVIDA LIMITED - AMERICAN DEPOSITOR (PSDV) Start Price: $5.00 Points: -47.57 Created: 01/01/2008 Comments: 0 | Comment shiningb Recs:

BUY: PSIVIDA LIMITED - AMERICAN DEPOSITOR (PSDV) Start Price: $2.40 Points: -1.85 Created: 01/01/2008 Comments: 0 | Comment jekebyfigahy Recs:

BUY: PSIVIDA LIMITED - AMERICAN DEPOSITOR (PSDV) Start Price: $2.74 Points: -12.66 Created: 01/01/2008 Comments: 0 | Comment Lynn827 Recs:

BUY: PSIVIDA LIMITED - AMERICAN DEPOSITOR (PSDV) Start Price: $1.82 Points: +26.16 Created: 01/01/2008 Comments: 0 | Comment WyomingSam Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
FGS		BUY	Three to Six Months	07/23/2011	$5.09	$2.11 (0.00%)	-58.54%	-2.02%	-56.52	view close
shiningb	36.28	BUY	Six Months to a Year	01/01/2008	$5.00	$2.11 (0.00%)	-57.80%	-10.23%	-47.57
jekebyfigahy		BUY	Six Months to a Year	01/01/2008	$2.40	$2.11 (0.00%)	-12.08%	-10.23%	-1.85
Lynn827	45.98	BUY	Six Months to a Year	01/01/2008	$2.74	$2.11 (0.00%)	-22.89%	-10.23%	-12.66
WyomingSam	65.91	BUY	Six Months to a Year	01/01/2008	$1.82	$2.11 (0.00%)	+15.93%	-10.23%	+26.16